Sign in

CIK 0001831915 · Accelerated filer

Cytek Biosciences, Inc.

Sign in to watch
Ticker
CTKB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472547526
Phone
(877) 922-9835
Business address
47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
  1. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $11.03 ($220,600)
  2. 4 Open-market sale President and CEO sold 20,000 shares at $10.66 ($213,200)
  3. 4 Open-market sale Chief Financial Officer sold 3,500 shares at $9.77 ($34,195)
  4. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $10.38 ($207,600)
  5. 4 Open-market sale President and CEO sold 20,000 shares at $11.86 ($237,200)
  6. 4 Option exercise Director acquired 23,999 shares (option exercise)
  7. 4 Open-market sale Chief Financial Officer sold 3,500 shares at $14.30 ($50,050)
  8. 4 Shares withheld for taxes President and CEO gave up 2,264 shares (to pay taxes)
  9. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $14.66 ($293,200)
  10. 4 Shares withheld for taxes General Counsel gave up 786 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 683 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP Bus. and Corp. Dev. gave up 308 shares (to pay taxes)
  13. 4 Open-market sale Director sold 16,000 shares at $14.69 ($235,040)
  14. 4 Open-market sale President and CEO sold 20,000 shares at $14.76 ($295,200)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Financial Officer sold 3,500 shares at $15.16 ($53,060)
  18. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $14.42 ($288,400)
  19. 4 Open-market sale President and CEO sold 20,000 shares at $14.79 ($295,800)
  20. 4 Open-market sale Chief Financial Officer sold 3,500 shares at $12.63 ($44,205)

Page 11 of 15 · 295 filings